Answers are grounded in this paper and cite their sources.
Reports that c-Myc inhibition reduces pyroptosis in cardiac endothelial cells, suggesting a potential treatment for microvascular injury.
Over the past few decades, most cardiac reperfusion research has focused on the pathogenesis of myocardial ischemia reperfusion injury (MIRI), while little attention has been paid to microvascular ischemia reperfusion (I/R) injury, and few strategies have been available to reverse this pathological process. c-Myc, a proto-oncogene, is related to cardiomyocyte apoptosis and inflammation. It has been reported that Sam68 is involved in inflammatory disorders. However, whether c-Myc and Sam68 can modulate pyroptosis in cardiac microvascular endothelial cells (CMECs) remains unknown.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: